Issues

Home > Issues (Page 22)

July 15, 2020 Infographics, Multimedia, Price and Costs

The Professor and Pete go to the movies to learn why there is a drug affordability problem. After watching a scary thriller about list prices and net prices, an adventure on the prescription escalator, and a movie on biosimilars, they learn that a) specific patient populations are impacted by the drug affordability problem; and b) these issues can be fixed with targeted reforms to achieve innovation and affordability....

July 14, 2020 Blog, Coronavirus

Miller talks with Lars Larson on the stategy to quarantine travelers from other states. New York recently moved to quarantine anyone visiting for at least two weeks. Miller points out that the logistics are difficult as the guidelines are different for those arriving by plane, train, or car, which could be as many as 120,000 people. Dr. Miller's segment begins at the 47-minute mark. Lars Larson National Podcast · Lars Larson National Podcast 07-14-20...

July 14, 2020 Coronavirus

The COVID-19 trends in the United States are moving in the wrong direction. More than 4,200 deaths occurred during the week of July 5th, and the highest number of new infections in a single day—more than 66,000—was reported on July 10th. As the numbers of cases, hospitalizations, and deaths surge to record levels in multiple epicenters, local and state officials are struggling with whether and how much to reverse the rollback of restrictions on individuals and businesses. For example, following a gradual reopening...

July 14, 2020 Coronavirus, Coronavirus Multimedia

Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is to bring drugs to market in the United States. Listen to the interview here. ...

July 14, 2020 Coronavirus

More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and its impact to continue reopening safely. If we put this knowledge to good use, we can craft policies that protect the most vulnerable while allowing those for whom the virus poses...

July 13, 2020 Coronavirus

It's clear from what people are posting on social media, and the questions they've submitted to Town Hall Q&As, that many are still unclear as to how the coronavirus that causes COVID-19 is transmitted, and what can be done to avoid it. The operative concept can be summarized in a single phrase: minimize the probability. Let's take a weather-related example as an analogy. Say it's sleeting, the temperature is 30 degrees, and the precipitation is forming a solid ice sheet as it...

July 12, 2020 Coronavirus

Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to talk about the latest changes in the coronavirus, or COVID-19, including the developments in the American southwest including steps the public can take to stop the spread of coronavirus and the dwindling number of hospital beds. Miller talks about why COVID-19 could be surging in some parts of the country and recent studies about the most common risks with the coronavirus. Larson and Miller also discuss examples from other countries...

July 9, 2020 Innovation

The COVID-19 crisis has tested America’s health care system like no other event in recent memory. One irony during this pandemic is that America has actually experienced the promise of health care innovation in an important way, namely through telehealth. Telehealth allows patients to talk with their doctors online using videoconferencing platforms. Doctors can see patients, discuss their symptoms, order tests, and even prescribe medication. Earlier this spring, as the coronavirus was becoming a serious problem across the country, Congress temporarily suspended regulations...

July 6, 2020 Coronavirus

PRI's Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA recently testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future vaccines will be vetted like any other vaccine evaluation (pre-critical data, manufacturing and controls, and clinical data). The FDA does have an elevated approval process for a drug that treats...

June 30, 2020 Coronavirus

By: Henry Miller, M.S., M.D., and Shiv Sharma, DDS As the nation slowly emerges from lockdown, we’re beginning to appreciate the full impact of the pandemic and that the sickness and death directly caused by the virus are only part of the picture. The three-month-plus suspension of routine, non-emergency medical care has created secondary, silent epidemics of untreated medical issues that require the urgent focus of both our public health officials and the public themselves. They include domestic violence and likely increases...

June 25, 2020 Coronavirus, Issues

Dr. Henry Miller talks about the status of a coronavirus vaccine on the Lars Larson Show. Miller comments on Dr. Anthony Fauci's estimate that a vaccine for COVID-19 could be available by the end of the year or as early as 2021. But, Dr. Miller said that Fauci's estimates are hugely optimistic. Lars Larson National Podcast · Lars Larson National Podcast 06-23-20...

June 23, 2020 Coronavirus, Issues

By: Henry Miller, M.S., M.D. and Kathleen Hefferon, Ph.D. COVID-19 has turned our world upside down in so many ways, and the food supply chain is no exception. Whether consumers prefer fast or slow food, meat-based or vegan, local or imported, organic or conventional, supermarkets or farmers' markets, every aspect of our food supply chain, from farm to fork, has been affected by this scourge. The recent, rampant outbreaks of COVID-19 among meat-processing workers – over the past month or so, the...

June 23, 2020 Coronavirus, Multimedia, Policy Proposals

As single-payer advocates such as Senator Bernie Sanders (I-VT) and House member Alexandria Ocasio-Cortez (D-NY) are seizing on the COVID-19 pandemic to push even more aggressively for a complete takeover of our health care system by the federal government, listen to a special presentation of our recent webinar featuring PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy Sally C. Pipes discussing why “Medicare for All” would be the wrong solution for the U.S. to embark on...

June 23, 2020 Coronavirus

Dr. Henry Miller talks about dangers from the United States sourcing a majority of active pharmaceutical ingredients, commonly called APIs, from China and other places impacted by the coronavirus, or COVID-19, pandemic. APIs can be considered the "important" component of a pill or medicine. Miller references a 2019 report by the U.S.-China Economic and Security Review Commission that highlights the growing reliance on China for APIs and problems with China's regulatory and quality control standards. Miller says more oversight and regulation...

June 18, 2020 Blog, Industry Trends

By: Kathleen Hefferon, Ph.D., and Henry Miller, M.S., M.D. COVID-19 has turned our world upside down in so many ways, and the food supply chain is no exception. Whether consumers prefer fast or slow food, meat-based or vegan, local or imported, organic or conventional, supermarkets or farmers’ markets, every aspect of our food supply chain, from farm to fork, has been affected by this scourge. The recent, rampant outbreaks of COVID-19 among meat-processing workers – over the past month or so, the...

June 17, 2020 Infographics, Price and Costs

 The Professor and Pete reach the most difficult part of their journey: understanding how medicines are sold. It’s a complex system that hurts patients and at times exposes them to paying excessive costs. They also learn that patients who get their prescriptions from a pharmacy don’t really benefit from drug discounts negotiated by pharmacy benefit managers (PBMs) – only PBMs and insurers do....

June 15, 2020 Blog, Coronavirus, Coronavirus - Alternate

By Andrew I. Fillat and Henry I. Miller With the world in the grip of the COVID-19 pandemic, most of the short-term focus is now on how to avoid surges of infections and get the economy functioning so people can go back to work. Hindsight is, of course, 20-20. Many lessons about pandemics will be learned in retrospect—the most notable being the need for epidemiological surveillance, preparedness with stockpiles of medical supplies, and how not to handle the most vulnerable population during...